Back to search

National and Kapodistrian University of Athens

Η επίδραση της συστηματικής χορήγησης ασβεστίου και βιταμίνης D στην πρόληψη του συμπτωματικού υποπαραθυρεοειδισμού και στην αναστροφή του μετά από ολική θυρεοειδεκτομή

Abstract

dc:description

Postoperative hypoparathyroidism and the consequent hypocalcemia represent the most common complication following total thyroidectomy and continue to constitute a significant clinical challenge in contemporary endocrine surgery. Their occurrence is associated with increased morbidity, prolonged hospitalization, the need for additional diagnostic and therapeutic interventions, higher healthcare costs, and impaired quality of life. Despite substantial advances in surgical technique and preventive strategies, considerable heterogeneity persists in the literature regarding the optimal postoperative management of this condition. Existing controversies concern not only the necessity of prophylactic supplementation but also the type of vitamin D preparation, calcium dosage, timing of initiation, and duration of treatment, reflecting the absence of universally accepted, high-level evidence-based protocols.Against this background, the present doctoral thesis was designed to comprehensively evaluate the role of prophylactic calcium and vitamin D supplementation in the prevention of postoperative hypocalcemia following total thyroidectomy. To achieve this objective, a dual and complementary research approach was adopted. First, a large prospective randomized controlled trial was conducted to assess the efficacy of a standardized postoperative calcium and alfacalcidol supplementation protocol in patients undergoing total thyroidectomy. Subsequently, a systematic review and Bayesian network meta-analysis of randomized controlled trials was performed to synthesize the available evidence and comparatively evaluate the principal supplementation strategies. By combining primary clinical research with secondary evidence synthesis, this thesis aimed to provide a comprehensive assessment of a topic that remains the subject of ongoing scientific debate and clinical uncertainty.The first research component consisted of a prospective, single-center, randomized, open-label superiority trial (ClinicalTrials.gov: NCT03777033), conducted at a tertiary center with extensive experience in endocrine surgery. A total of 600 consecutive adult patients undergoing total or near-total thyroidectomy for benign or malignant thyroid disease, without concomitant central or lateral neck dissection, were enrolled. Patients with a history of previous neck surgery or radiotherapy, known parathyroid disease, preoperative calcium or vitamin D supplementation, or medications known to affect calcium metabolism, including corticosteroids, diuretics, or bisphosphonates, were excluded.Participants were randomized in a 1:1 ratio into two groups of 300 patients each. The intervention group received prophylactic oral calcium and alfacalcidol for a total of 15 postoperative days: 3 g of calcium and 1 μg of alfacalcidol daily during the first five postoperative days, followed by 2 g of calcium and 0.5 μg of alfacalcidol daily for additional ten days. The control group received standard postoperative care without routine supplementation and was treated only when clinical or biochemical indications arose. The primary study endpoints were the occurrence of clinical or biochemical hypocalcemia and the requirement for intravenous calcium administration during the early postoperative period. Secondary endpoints included postoperative calcium levels and length of hospital stay.Overall, biochemical hypocalcemia occurred in 26.1% of patients, mild clinical hypocalcemia in 8.3%, and 4.7% required intravenous calcium administration because of severe symptoms. Prophylactic calcium and alfacalcidol supplementation was associated with a significant reduction in biochemical hypocalcemia (16.9% vs. 39.9%, OR 0.305, 95% CI 0.207–0.451, p<0.001), clinical hypocalcemia (5.6% vs. 12.3%, OR 0.427, 95% CI 0.232–0.785, p=0.005), and the need for intravenous calcium administration (1.8% vs. 9.3%, OR 0.175, 95% CI 0.070–0.441, p<0.001). Furthermore, implementation of the protocol resulted in a significantly shorter hospital stay (1.25 vs. 1.70 days, p<0.001). The intervention proved highly safe, with only one episode of clinically significant hypercalcemia requiring readmission and no other serious treatment-related adverse events.Pre-specified subgroup analyses confirmed the consistency of these findings across different patient populations. Specifically, prophylactic calcium and alfacalcidol administration remained effective in both benign and malignant thyroid disease, demonstrating a similar protective effect against postoperative hypocalcemia and indicating that the benefit of the protocol was independent of the underlying thyroid pathology. In addition, subgroup analysis according to preoperative 25-hydroxyvitamin D levels demonstrated that the favorable effect of prophylactic supplementation was maintained regardless of baseline vitamin D status, although the magnitude of benefit appeared greater among patients with vitamin D deficiency or insufficiency (<30 ng/mL). Collectively, these findings support the generalizability of the results and reinforce the clinical applicability of the proposed protocol across a broad spectrum of patients undergoing total thyroidectomy.The second research component comprised a systematic review and Bayesian network meta-analysis conducted in accordance with the PRISMA 2020 guidelines and prospectively registered in PROSPERO (CRD420251068837). Twenty randomized controlled trials involving a total of 3,669 patients undergoing total thyroidectomy with or without cervical lymph node dissection were included. The evaluated interventions were grouped into three treatment nodes: no prophylactic supplementation, calcium monotherapy, and combined calcium plus vitamin D or active vitamin D metabolite supplementation. The network meta-analysis framework enabled both direct and indirect comparisons among the available strategies, providing a comprehensive estimate of their relative effectiveness.The primary outcomes were clinical hypocalcemia, biochemical hypocalcemia, and the requirement for intravenous calcium administration, whereas length of hospital stay was evaluated as a secondary outcome. Bayesian random-effects models demonstrated excellent convergence (Gelman–Rubin statistic <1.05). Network consistency and validity were assessed using node-splitting analyses and the Unrelated Mean Effects model, which allows the detection of potential inconsistency between direct and indirect evidence. Multiple pre-specified sensitivity analyses were also performed through the sequential exclusion of studies at high risk of bias, studies including preoperative supplementation, studies using native vitamin D preparations, and studies involving routine or high rates of central neck dissection, in order to evaluate the robustness and reliability of the findings.Combined calcium and vitamin D supplementation consistently emerged as the most effective preventive strategy. Compared with no prophylactic treatment, combination therapy significantly reduced the risk of clinical hypocalcemia (OR 0.31, 95% CrI 0.17–0.51), biochemical hypocalcemia (OR 0.27, 95% CrI 0.17–0.42), and the requirement for intravenous calcium administration (OR 0.15, 95% CrI 0.05–0.32). In contrast, calcium monotherapy demonstrated only intermediate effectiveness and did not consistently achieve statistically significant superiority over no supplementation. Ranking analyses (SUCRA and Litmus Rank-O-Gram) consistently identified calcium plus vitamin D supplementation as the highest-ranked intervention across all major outcomes, while it was also associated with shorter hospital stay. The results remained essentially unchanged across all sensitivity analyses, supporting the robustness and reliability of the findings.Overall, the findings of the two research components were complementary and converged toward the same consistent conclusion. The prospective randomized clinical trial demonstrated, under real-world clinical conditions, the efficacy and safety of a specific prophylactic calcium and alfacalcidol supplementation protocol, whereas the systematic review and Bayesian network meta-analysis confirmed, at a broader level of evidence, the superiority of combined calcium and vitamin D supplementation over alternative preventive strategies.In conclusion, routine prophylactic administration of calcium in combination with active vitamin D following total thyroidectomy represents an effective, safe, and clinically applicable strategy for reducing biochemical and symptomatic hypocalcemia, the need for intravenous calcium therapy, and length of hospital stay. The findings of the present doctoral thesis strengthen the available scientific evidence and support the implementation of standardized supplementation protocols in the postoperative management of patients undergoing total thyroidectomy.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Gkanis, Vasileios
  • Γκάνης, Βασίλειος

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/62951

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-21
Source record
OAI-PMH GetRecord
citation

Gkanis, Vasileios; Γκάνης, Βασίλειος. Η επίδραση της συστηματικής χορήγησης ασβεστίου και βιταμίνης D στην πρόληψη του συμπτωματικού υποπαραθυρεοειδισμού και στην αναστροφή του μετά από ολική θυρεοειδεκτομή. National and Kapodistrian University of Athens, 2026. http://hdl.handle.net/10442/hedi/62951